NEUROONE MEDICAL TECHNOLOGIES CORPORATION

Autres langues NeuroOne Medical Technologies Corporation

Actions

NMTC

US64130M2098

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
1,21 ^USD	+4,31 %		+9,01 %	-23,42 %

26/03	NeuroOne Medical Technologies Corporation lance le lancement commercial limité de son système d'ablation OneRF	CI
13/02	Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	10/04
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	09/04
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04/04
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	26/03
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	26/03
NeuroOne to Participate in the 36th Annual Roth Conference	11/03
NeuroOne® to Participate in the 36th Annual Roth Conference	08/03
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	13/02
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13	08/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	14/12
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update	14/12
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall	11/12
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System	11/12
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System	11/12
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14	07/12
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?	05/12
NeuroOne Medical Technologies Gets Notice of Allowance for Drug Delivery Patent	16/11
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe	16/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues NeuroOne Medical Technologies Corporation

Actions

NMTC

US64130M2098

Autres langues

Filtres